Combining Molecular Markers With the TNM Staging System to Improve Prognostication in Stage II and III Colon Cancer: Are We Ready Yet?

Frank A. Sinicrope and Qian Shi

首页> 外文期刊>Journal of the National Cancer Institute >Combining Molecular Markers With the TNM Staging System to Improve Prognostication in Stage II and III Colon Cancer: Are We Ready Yet?

【24h】

Combining Molecular Markers With the TNM Staging System to Improve Prognostication in Stage II and III Colon Cancer: Are We Ready Yet?

机译：将分子标记物与TNM分期系统相结合以改善II期和III期结肠癌的预后：我们准备好了吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the National Cancer Institute》 |2012年第21期|p.1616-1618|共3页
作者
Frank A. Sinicrope and Qian Shi;
展开▼
作者单位

Affiliations of authors: Department of Medicine (FAS) and Department of Biomedical Statistics &

Informatics (QS), Mayo Clinic and Mayo Cancer Center, Rochester, MN.;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Combining molecular markers with the TNM staging system to improve prognostication in stage II and III colon cancer: Are we ready yet? [J] . SinicropeF.A., ShiQ. Journal of the National Cancer Institute . 2012,第21期

机译：将分子标记物与TNM分期系统相结合以改善II期和III期结肠癌的预后：我们准备好了吗？
2. Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival [J] . Walker Richard, Wood Trevor, LeSouder Emily, Journal of Surgical Oncology . 2018,第5期

机译：两种新型分期系统与TNM系统预测III阶段结肠癌存活的比较
3. P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management [J] . Qi Liu, Dakui Luo, Sanjun Cai, Cancer Management and Research . 2018,第4期

机译：结肠癌的P–TNM分期系统：P期和AJCC TNM分期系统的组合可改善预后预测和临床管理
4. What the Standard Pathology Lab Can Provide in Terms of Markers: Not All Stage II Colon Cancers Are Equal [C] . Wade S. Samowitz Gastrointestinal Cancers Symposium . 2014

机译：标准病理实验室可以在标记方面提供什么：并非所有阶段II阶段结肠癌都是平等的
5. The Association of Hospital and Patient Characteristics with Treatment Initiation among Veterans with Stage I, II, or III Lung, Colon or Rectal Cancer [D] . Clary, Alecia S. 2019

机译：具有阶段I，II或III肺，结肠或直肠癌的退伍军人治疗发起的医院和患者特征
6. P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management [O] . Qi Liu, Dakui Luo, Sanjun Cai, 2018

机译：结肠癌的P–TNM分期系统：P期和AJCC TNM分期系统的组合可改善预后预测和临床管理
7. Marine omega‐3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance) [O] . Mingyang Song, Fang‐Shu Ou, Tyler J. Zemla, 2019

机译：海洋ω-3脂肪酸摄入和存活阶段III结肠癌根据NCCTG期III试验N0147（联盟）的肿瘤分子标记

Combining Molecular Markers With the TNM Staging System to Improve Prognostication in Stage II and III Colon Cancer: Are We Ready Yet?

著录项

相似文献

相关主题

期刊订阅